Association between dexamethasone exposure and visually significant cataracts in multiple myeloma

Am J Hematol. 2024 Jan;99(1):E12-E14. doi: 10.1002/ajh.27133. Epub 2023 Oct 18.

Authors

Rahul Banerjee^{1

2}, Jorge Arturo Hurtado Martínez³, Patricia Alejandra Flores Pérez³, Nolan Porras³, Jay Hydren³, Jennifer M Ahlstrom³, Parisa Taravati⁴, Andrew J Cowan^{1

2}

Affiliations

¹ Department of Medicine, University of Washington, Seattle, Washington, USA.
² Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
³ HealthTree Foundation, Lehi, Utah, USA.
⁴ Department of Ophthalmology, University of Washington, Seattle, Washington, USA.

PMID: 37853832
DOI: 10.1002/ajh.27133

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Bortezomib / therapeutic use
Cataract* / chemically induced
Dexamethasone / adverse effects
Humans
Multiple Myeloma* / complications
Multiple Myeloma* / drug therapy

Substances

Bortezomib
Dexamethasone